Efficacy and Safety Evaluation of B-Domain Deleted Recombinant Porcine Factor VIII (rpFVIII, TAK-672), in Japanese Participants With Acquired Hemophilia A (AHA)

Condition:   Acquired Hemophilia A Intervention:   Biological: TAK-672 Sponsor:   Takeda Not yet recruiting

Source: ClinicalTrials.gov - October 8, 2020 Category: Research Source Type: clinical trials